Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Ovarian Cancer Recurrent × liposomal doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Fallopian Tube Neoplasms 4 Sarcoma 1 Ovarian Cancer Recurrent 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

mirabegron 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06791460 2025-03-18

Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

Obstetrics & Gynecology Hospital of Fudan University

Phase 2/3 Recruiting

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡